Radioiodine therapy is highly effective for feline hyperthyroidism, but post-treatment management is essential to ensure long-term welfare outcomes.
Radioiodine therapy offers a welfare-positive alternative to lifelong daily medication for hyperthyroid cats. However, the mandatory post-treatment isolation period is a significant welfare consideration, as cats must be housed in a specialist facility away from their owners and familiar environment. Isolation stress can be minimised through environmental enrichment and remote owner contact where facilities permit. Post-treatment monitoring is critical because renal disease unmasked by normalising cardiac function can progress rapidly. Owners must commit to follow-up blood testing schedules to detect hypothyroidism or deteriorating kidney function that requires prompt intervention.